Get our introductory offer at only
Cancel anytime
*$0.99/month for first 3 months
$29.90/month for the next 9 months
London
SHARES in AstraZeneca fell more than 5 per cent on Thursday after the company declined to deny a media report that chief executive Pascal Soriot was about to defect to Israel-based Teva Pharmaceutical Industries.
Mr Soriot, who has led the...